The aim of this study was to identify mutations in the D-loop region of mtDNA in head, neck, and limb tumours in dogs, and determination of their relationship with the process of neoplastic transformation. Blood and tumour tissue samples from 19 dogs with diagnosed sporadic malignant tumours were analysed. DNA extraction, amplification, and sequencing of the mtDNA D-loop, and bioinformatic analyses were performed. Five mutations and 19 polymorphisms were observed in 68.42% of all tumours. Polymorphic variants were noted in 42.86% of the head and neck tumours and in 58.33% of the limb tumours. Mutations were observed in 21.05% of dogs. The mutations were found in 28.57% of the head and neck tumours and in 16.66% of the limb tumours. The mutations were identified in 50% of the studied epithelial cancers. In the mesenchymal tumours, no mutations in the D-loop region were observed. Mitochondrial haplotype A17 was found in over 40% cases of limb tumours. No association between the age, breed, sex, type of tumour, and detected polymorphic variants were observed. Different mutational changes in the D-loop sequences of mtDNA identified in the blood and tumour tissues may indicate a relationship between the type of tumour and individual changes in the D-loop nucleotide sequences of mtDNA.
Introduction
According to Kim et al. (16) , the complete nucleotide sequence of the domestic dog mitochondrial genome consists of 16727 bp, and the non-coding control region (mtCR) or D-loop is located between positions 15458-16727 (1270 bp), where the presence of a heteroplasmic repeat unit divides the mtCR into two subsections, hypervariable region I (HVI) and hypervariable region II (HVII) (15, 23) .
Analysis of mitochondrial DNA (mtDNA) sequences plays an important role in the studies on population genetics and in medicine, including veterinary medicine (7, 11, 12, (27) (28) (29) 32) . Results published in the recent years have indicated the prevalence of mitochondrial DNA mutations in tumour cells, which suggests that they may be cancer-causing agents (7, 11, 12, 28, 29, 32, 34) . Up till now, there has been not stated whether the observed changes in mitochondrial DNA result from the development of tumour or are connected with the process of neoplastic transformation (7, 11, 12, 28, 29) . GrzybowskaSzatkowska and Slaska (12) report the presence of homological changes in the sequence of mtDNA in breast cancer and some mitochondrial diseases, which indicates that mutations in mtDNA in breast cancer may affect the cell and cause its dysfunction, as in the case of mitochondrial diseases.
The molecular basis of many human tumours attracts much more attention than in the case of animal tumours. Growing expectations of breeders and dog owners with regard to diagnosis and treatment encourage scientists to undertake extensive research in this area. Rowell et al. (25) report that about 400 diseases in dogs and humans are analogous in the genetic background and course. Certain types of tumours, such as canine mammary carcinoma, are genetically, morphologically, clinically, and prognostically related to human tumours. Hence, the dog is a suitable animal model for naturally occurring tumours (18, 24, 25, (31) (32) (33) .
The studies on tumour tissues showed a significant number of somatic mutations in mtDNA (3, 7, 11, 12, 22, 28, 29) , especially in the D-loop region which controls replication and transcription of mitochondrial DNA. These mutations can lead to disorders in these processes and cell energy functions (7, 11, 17) . Therefore, the mutations identified in the D-loop region may affect the mitochondrial electron transport chain, which is responsible for release of reactive oxygen species (ROS). High level of ROS may lead to changes in the mitochondrial genome and initiation of tumour growth (7, 11, 32, 34) .
The breed specific predispositions to malignant tumours in dogs indicate a significant genetic component of neoplastic transformation. In many cases, the aetiology of human and canine genetic diseases is similar because of the orthology of genes, in which mutations causing genetic disorders in the process of malignant transformation are located (32) . Identification of risk factors may increase prognostic and diagnostic possibilities in the case of human and canine tumours. Somatic mutations in mtDNA have been described in many types of human tumour cells (7, 8, 11-13, 17, 20, 21, 34) , but there are only a few literature reports documenting the occurrence of mutations in the mtDNA of dogs with tumours (3, 22, 28, 29, 32) . Mutations may occur in the entire mitochondrial genome but, most often, they occur in the hypervariable regions of the D-loop (3, 22, 28, 29, 32) . Therefore, an attempt is made to identify mutations in the mitochondrial D-loop and connect them with the process of carcinogenesis in dogs.
Dog's clades are marked with the use of capital letters (from A to F) (26) . Networks reported by Savolainen et al. (26) show sub-hierarquisation especially within clade A, and the further indication of the positions will make it possible to easily classify sub-clades. According to Imes et al. (15) , 10 most commonly observed mtGenome HVI haplotypes (A2, A11, A16, A17, A18, A19, A22, A26, B1, C3) compose approximately 53% of the sequenced canine mtDNA. The remaining mtGenomes exhibit one of 118 HVI haplotypes. Phylogenetic analysis of Savolainen et al. (26) assigned the dog sequences into the same four phylogenetic groups (clades A, B, C, and D) and to clades E and F, consisting of an isolated haplotype. Haplotypes of clades D, E, and F were found only regionally (26) . A total of 71.3% of all dog populations worldwide has haplotypes belonging to clade A, and 95.9% has the types belonging to clades A, B, or C. Clade A has been shown to be represented in all geographic regions, and clades B and C in all regions except America. The frequencies of clades A, B, and C are similar in all regions and there is no clear division of the main morphologic types of dogs or of large and small breeds among the three main clades (26) .
In the literature there is no information about the relationship between dog's mitochondrial haplotypes and neoplasia in dogs. The most common and most widely studied tumours in dogs are breast cancers as well as head and neck tumours. Other types of tumours, such as gastrointestinal and limb tumours occur less frequently (4, 10, 19, 30, 32, 35) . There are no reports about genetic determination of limb tumour. The aim of this study was the identification of mutations in the Dloop region of mtDNA in head, neck, and limb tumours in dogs and determination of their relationship with the process of neoplastic transformation.
Material and Methods
Thirty-eight samples obtained from blood (n = 19) and tumour tissues (n = 19) of 19 dogs of 11 different breeds and six crossbreeds were analysed. The breed specifications and malignant tumour types of preliminary studies are given in Table 1 .
The dogs received no chemotherapy or hormone therapy. Analyses were performed on DNA isolated from post-operative tissues. Tumour tissues were collected along with blood.
Prior to DNA isolation, the histological type of the individual tissue was routinely assessed. Sections were sampled from each surgically removed tumour for histopathological analyses. The tissues were fixed in buffered formalin, embedded in paraffin blocks, and preparations were stained with haematoxylin and eosin. Microscopic assessment of tumours was performed in accordance with the WHO histological recommendations (International Classification of Tumours of Domestic Animals).
DNA was extracted from tumour tissues and their matched blood samples using the DNeasy Blood & Tissue Kit (Qiagen). DNA samples were assessed quantitatively and qualitatively by electrophoretic separation in agarose gel and spectrophotometrically by measurements of sample absorbance in a BioPhotometer (Eppendorf, Germany) spectrophotometer.
Amplification of the non-coding mitochondrial DNA region, i.e. the D-loop, was performed using the PCR technique in a MJ Research PTC 225 Tetrad thermal cycler. Primers used in the analysis, encompassing a mtDNA fragment between nucleotide 15341 and 15804 (LF 5`-TTACCTTGGT CTTGTAAACC; HR 5`-CTGAAGTAAGAACCA GATGCC), were found in literature reports (2) . The annealing temperature (Ta -48ºC) and amplification conditions were established experimentally. Amplification products were visualised on 2% agarose gel. Amplicons were sequenced using a BigDye Terminator Cycle Sequencing kit (Applied Biosystem, USA) in GeneAmp PCR system 9700 (Applied Biosystem, USA). The samples were subsequently purified on CentriSep columns according to the manufacturer's protocol or precipitated with ethanol and sodium acetate according to the protocol of the BigDye kit manufacturer. Extension products were separated on an ABI 377 automated sequencer (Applied Biosystem, USA).
The nucleotide sequences obtained were subjected to bioinformatic analyses (1, 14) in order to determine mutation and polymorphic sites within the analysed mtDNA fragment in each of the tissues sampled from the individuals and in the groups of head, neck, and limb tumours (9) 
Results
Among the studied tumours, mastocytoma constituted the largest group (21%). Haemangiopericytoma was the most common neoplasia (25%) in the group of limb tumours ( Table 1) . Tables  2-4 show the results of analysis of D-loop sequences in different tissues of dogs with diagnosed tumours. 15435C  15526G  15595G  15612A  15632G  15639A  15643T  15652C   15435T  15526A  15595A  15612G  15632A  15639C  15643C  15652T   15435T  15526A  15595A  15612G  15632A  15639C  15643C 15652T Analysis of sequences of the mtDNA hypervariable region in dogs with tumours showed a relatively high level of genetic variability. Mutations and/or polymorphisms in the D-loop fragment were found in 68.42% cases of tumours. Substitutions relative to the reference sequence were identified in 52.6% of all analysed tumours (Tables 2, 3 ). Polymorphic variants were noted in 42.86% of the head and neck tumours and in 58.33% of the limb tumours. Mutations were observed in 21.05% dogs with tumours (Figs 1, 2) . These mutations were found in 28.57% of the head and neck tumours and in 16.66% of the tumours of limbs. All tumours with mutations were epithelial neoplasms, and the mutations occurred in 50% of epithelial cancers (Tables 1, 4 ). In the studied material, majority of the detected changes were homoplasmic. Heteroplasmy was observed in one case of limb epithelial cancer -carcinoma hidradenoides (Table 4 , Fig. 2 ).
Mitochondrial haplotype A17 was found in over 40% cases of limb tumours (Table 1) . A change in the position 15 639 was identified in 57.90% of all tumours. Polymorphism A15627G was also frequently observed (36.84% of tumours). The changes occurred in different tumours, independently of the occurrence site and origin (Tables 2, 3) . Substitutions in positions T15475C and T15665C were identified in carcinoma planoepithelialae keratodes and haemangiopericytoma (Table 3 ). In eight positions (G15435A, C15526T, C15595T, T15612C, C15632T, T15639G, A15643G, G15652A), the changes occurred in carcinoma sebaceum and lipoma. Polymorphisms, which accounted for 61.1% of all the polymorphic changes observed, were identified in all dogs with diagnosed haemangiopericytoma tumour.
In the group of head and neck tumours, polymorphism T15639A was observed in carcinoma glandulae thyroideae and mastocytoma G2 (Table 2) and polymorphism T15639G was detected in carcinoma sebaceum. Majority of polymoprhisms were identified in the case of carcinoma sebaceum (Table 2) . Mutations were noted in carcinoma glandulae thyroideae (A15483G, A15620G) and epithelioma sebaceum (T15639A) ( Table 4 , Fig. 1 ). These sequences differed in the tumours and blood. In the case of three tumours of the head and neck (27, 37, 64) , there were no differences between the D-loop sequence and the reference sequence (Tables 1, 2, 4) .
In group of limb tumours and in group of head and neck tumours, the change in position 15 639 was observed in all individuals with polymorphisms (Table 3) . In all angioma tumours, which occurred only in limbs, many changes were identified in the D-loop region. The mutations were noted in carcinoma hidradenoides (G15529G/A) and carcinoma basocelullare (T15627C) ( Table 4) . Heteroplasmy was identified in tumour tissue (G15529G/A). In this case, correct (G15529) nucleotide sequence was noted in blood (Fig. 2) .
In the case of three tumours of limbs (52, 91, 95), there were no differences between the D-loop sequence and the reference sequence (Tables 1, 3, 4) .
Discussion
Defects in mitochondrial DNA have been studied for many years in order to determine their role in progression of cancer. The differences in energy metabolism of tumour and normal cells are the biochemical basis for speculation about the therapeutic strategies, which in the future can be used for selective killing of tumour cells (5) . Previous studies concerned mainly mutations in human mtDNA in carcinogenesis (7, 11, 12, 34) . Only a few authors have conducted investigations on the relationship between mutations and carcinogenesis process in dogs (3, 22, 28, 29) .
Bertagnolli et al. (Tables 2-4 ) and previous studies (29) .
The presence of more than one type of mtDNA in an organism (heteroplasmy) is the result of recombination in mtDNA (8) . Heteroplasmy was found in this study in carcinoma hidradenoides (Table 4 , Fig. 2 ). Investigations on changes in the nucleotide sequence of the D-loop in oral tumours were conducted by Lin et al. (20) . Mutations were identified in 64% of patients; 68.4% of these mutations were heteroplasmic. There was no relationship between the studied factors (age, sex), tumour localisation, histopathological features, stage, smoking, alcohol consumption), and groups. In contrast to that, the present study indicated the occurrence of only one heteroplasmy in the nucleotide sequence in position G15529G/A ( Table 3) . The presence of this change in only one individual may be related to the very low frequency of heteroplasmy in tumour cells in dogs.
All mutations and polymorphic changes observed in the present study were single nucleotide substitutions (Tables 2-4) . A study on six cell lines of squamous head and neck tumour was conducted by Challen et al. (6) . Analysis showed the presence of six substitutions in the HVS1. The authors found no association between the identified changes and the age, sex, tumour localisation, and stage of tumour. In this paper, no relationship between the age, breed, sex, tumour type, and the localisation of polymorphic changes in the nucleotide sequence of the D-loop was observed. Similar results were shown by Lin et al. (20) and Challen et al. (6) . All tumours with mutations were epithelial cancers (Tables 1, 4 ). Mitochondrial haplotype A17 was found in over 40% cases of limb tumours (Table 1) . Moreover, no relationship between the haplotype and the tumour type was observed (Tables 1-4) .
Studies on mutations in the D-loop sequence were also conducted by Lièvre et al. (21) . Their analyses involved patients with head and neck tumours. Twentyfive mutations were identified in 23 individuals. These mutations were mostly several basis-pair deletions and insertions. In our present and previous research (28, 29) , no deletions or insertions were identified in malignant tumours in dogs.
This study demonstrated the occurrence of 19 polymorphic changes in 53% of tumours. The most common polymorphism was substitution in position 15639 (substitution T/A or T/G). The association between changes in the sequence of the D-loop region of mtDNA and larynx tumour was identified by Guo et al. (13) . In total, 34 mutations in the hypervariable region of the D-loop were identified in more than 50% of the studied individuals. In addition, 86 polymorphisms were identified. In the present study, five mutations and many polymorphic changes were observed (Table 4 ). All tumours with mutations were epithelial cancers, irrespective of tumour localisation. These mutations occurred in 50% of all studied epithelial cancers.
